Tidewater Accountable Care Organization, LLC Name and Location

Tidewater Accountable Care Organization, LLC
Tidewater Medical Center
860 Omni Boulevard, Suite 401
Newport News, Virginia  23606

Tidewater Accountable Care Organization, LLC Primary Contact

Contact:  Sibyl Wilson, COO
Phone:  (757) 232-8764
Email:  [email protected]

ORGANIZATIONAL INFORMATION

Tidewater Accountable Care Organization, LLC Participants

Tidewater Accountable Care Organization, LLC (TACO) Governing Body

Key ACO Clinical and Administrative Leadership

• ACO Executive: Linda Larue
• Medical Director:  Jeffrey Morrison, DO, FACOG
• Compliance Official:  Jeffrey Morrison, DO, FACOG
• Quality Assurance/Improvement Officer:  Jeffrey Morrison, DO, FACOG

Tidewater Accountable Care, LLC Organization Associated Committees and Committee Leadership

Types of Accountable Care Organization Participants, or Combinations of Participants, that Formed the Accountable Care Organization

ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

• Third Agreement Period
  • Performance Year 2020, $5,116, 002

• Second Agreement Period
  • Performance Year 2019, $0
  • Performance Year 2018, $0
  • Performance Year 2017, $0

• First Agreement Period
  • Performance Year 2016, $0
  • Performance Year 2015, $0
  • Performance Year 2014, $0

Shared Savings Distribution

• Third Performance Period
  • Performance Year 2020
    • Proportion invested in infrastructure:  3%
    • Proportion invested in redesigned care processes/resources: 35%
    • Proportion of distribution to ACO participants: 62%

• Second Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

• • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
• • Performance year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

2020 Quality Performance Results

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

The Secretary of U.S. Department of Health and Human Services has provided waivers of certain federal laws that may otherwise limit innovation by ACOs. In accordance with the public disclosure requirements of the ACO Participation Waivers set forth in 80 Fed. Reg. 66725 (Oct. 29, 2015), the applicable arrangements are described below:

Agreements with LabCorp: The parties to the arrangement include Tidewater Multispecialty Groups, P.C. (TPMG) and Laboratory Corporation of America Holdings and its subsidiaries (“LabCorp”). The agreements are effective as of December 8, 2021 . Under the agreements, the parties will coordinate with each other to meet requirements for reporting quality and cost measures, establish clinical decision support programs to support chronic disease management and population health strategies, and evaluate and address the health needs of Tidewater Multispecialty Groups, P.C. (TPMG)’s patient population. LabCorp will make available laboratory testing services to Tidewater Multispecialty Groups, P.C. (TPMG)’s providers, and Tidewater Multispecialty Groups, P.C. (TPMG) will integrate and use this information in Tidewater Multispecialty Groups, P.C. (TPMG)’s data analytics programs, reporting measures, and care coordination and intervention strategies. The agreements include a series of potential grants to develop infrastructure and redesigning care processes to allow for high quality and efficient service delivery for patients whereby Tidewater Multispecialty Groups, P.C. (TPMG) must meet certain quality metrics to be eligible. This arrangement allows the parties to promote accountability for the quality, cost and overall care for Tidewater Multispecialty Groups, P.C. (TPMG)’s patients and manage and coordinate care for these individuals. With respect to this arrangement above, Tidewater Multispecialty Groups, P.C. (TPMG)’s governing body has made and duly authorized a bona fide determination that the arrangement is reasonably related to the purposes of the Medicare Shared Savings Program.

Questions?

For more details about our ACO, ask the front desk for a copy of the ACO beneficiary notice. If you have questions or concerns, call us at 757-260-9020 or we can talk about them during your visit in our office. You can also call 1-800-MEDICARE or visit Medicare.gov/acos.html.